S2. Ep 9: A patient perspective - navigating chronic disease and pharma's role in improving lives

(18:41)

Reuters Pharma USA 2024 – Lung-I Cheng

(12:30)

Reuters Pharma USA – Ligia Del Bianco

(9:)

Reuters Events: Pharma 2025 - The world’s leading cross-functional event for pharma changemakers

(2:24)

Reuters Pharma USA 2024 – Serena Goodwin

(8:4)

Expect high, volatile yields to be a 'feature, not a fluke' in the coming months: Lauren Goodwin

(6:2)

The Real Reason of Market Crash! - 3 Reasons Why It Fell

(32:28)

Harburg: Musk's ties with China benefit this deal.

(3:44)

Market Navigator: Health care picks for 2025

(2:58)

China, India refiners scour the world for oil supplies amid US sanctions on Russia | REUTERS

(1:39)

Los Angeles wildfires spark insurance anxiety among victims • FRANCE 24 English

(10:3)

Global Economy Braces for Trump Tariffs, Inflation, Climate Change in 2025 | Firstpost Tech \u0026 Trade

(11:12)

WEBINAR: HCPs are omnichannel. Is your marketing strategy?

(1:38)

Reuters Pharma USA – Lung-I Cheng

(12:34)

Reuters Pharma 2024 Recap

(5:19)

Careful Not to be Dependent on China: Tadeka Pharmaceutical CEO

(8:2)

Reuters Pharma USA 2024 – Mindy McGrath

(12:29)

Reuters Pharma USA – Maria Whitman

(14:31)

Big pharma: GSK beats forecasts, but Novartis lags

(1:14)

Reuters Pharma 2022 - medical affairs and technology with Lance Hill

(9:29)

Conference report: Reuters Pharma USA

(38:3)

Reuters Events: Pharma Customer Engagement Europe 2022

(1:1econd)

Reuters Pharma USA 2024 – Jeffrey Meckler

(12:41)

Conference report: Reuters Pharma Europe

(37:26)

PharmaPulse S2. Ep 8: Leveraging innovation for patient-centric progress with Harmony Garges

(8:24)

The potential of AI in pharma: interview with Subhro Mallik, EVP Head of Life Sciences, Infosys

(11:24)